Regenex Corporation Co. Ltd. is a pioneering pharmaceutical company founded in 2003, specializing in the advancement of reproductive and chronic health. Their dedication to research, development, production, and distribution of medications in the biotechnology, health care, and pharmaceutical sectors sets them apart. The company's precision in marketing and distribution is evident through the utilization of GPS track management for marketing teams and standardized terminal methods for marketing efforts. Regenex Corporation recently secured a significant CNY100.00M Series C investment on 16 June 2023 from a consortium of esteemed investors including Fortune Venture Capital, GF Securities, Guangzhou Industrial Investment Group, and Chuangyu Investment Management. This substantial investment is a testament to the company's potential for growth and innovation in the pharmaceutical industry.
No recent news or press coverage available for Regenex Corporation Co. Ltd..